-
IntroducedApr 23, 2025
-
Passed SenateMay 08, 2025
-
Passed House
-
Signed into Law
TAX EXEMPTIONS: Provides relative to the sales and use tax exemption for the sale of certain prescription drugs. (gov sig) (EG SEE FISC NOTE LF RV See Note)
Last Action See all actions
House • May 29, 2025: Read by title, passed to 3rd reading.
Latest Bill Text See all bill texts
House Calendar: Senate Bills on Third Reading and Final Passage Not yet scheduled for floor debate
Position: 40
Summary/Bill Text
Comments on SB 243
Tweets
Whip Lists
Sponsors
Votes
Actions
- May 29, 2025 | House
- Read by title, passed to 3rd reading.
- May 28, 2025 | House
- Reported without Legislative Bureau amendments.
- May 27, 2025 | House
- Reported favorably (14-0). Referred to the Legislative Bureau.
- May 13, 2025 | House
- Read by title, under the rules, referred to the Committee on Ways and Means.
- May 12, 2025 | House
- Received in the House from the Senate, read by title, lies over under the rules.
- May 08, 2025 | Senate
- Read by title, passed by a vote of 31 yeas and 0 nays, and sent to the House. Motion to reconsider tabled.
- May 07, 2025 | Senate
- Read by title. Committee amendments read and adopted. Ordered engrossed and passed to third reading and final passage.
- May 06, 2025 | Senate
- Reported with amendments.
- Apr 28, 2025 | Senate
- Read second time by title and referred to the Committee on Revenue and Fiscal Affairs.
- Apr 23, 2025 | Senate
- Introduced in the Senate. Read by title and placed on the Calendar for a second reading.